Skip to main content
Clinical Trials/NCT00131170
NCT00131170
Completed
Phase 4

Paravertebral Block for Breast Surgery

University of Aarhus1 site in 1 country90 target enrollmentSeptember 2005
ConditionsBreast Cancer

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
University of Aarhus
Enrollment
90
Locations
1
Primary Endpoint
Nausea and vomiting 2 hours postoperatively, and 1 and 2 days postoperatively
Status
Completed
Last Updated
18 years ago

Overview

Brief Summary

The effect of paravertebral block in combination with general anaesthesia is studied in a double blind fashion.

Detailed Description

Patients having surgery for breast cancer receive a paravertebral blockade at C8-Th4 with either Naropin 0.5% or saline. General anaesthesia is then provided with laryngeal mask intubation, propofol infusion and fentanyl i.v. as needed. The effect on postoperative pain (\[VAS\] and fentanyl PCA doses taken) and postoperative nausea and vomiting is recorded.

Registry
clinicaltrials.gov
Start Date
September 2005
End Date
September 2006
Last Updated
18 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Breast surgery

Exclusion Criteria

  • Infections
  • Coagulation disorder

Outcomes

Primary Outcomes

Nausea and vomiting 2 hours postoperatively, and 1 and 2 days postoperatively

Time Frame: 2 days

Secondary Outcomes

  • Dosage of analgesic(1 day)

Study Sites (1)

Loading locations...

Similar Trials